Epigenetic modifications in KDM lysine demethylases associate with survival of early-stage NSCLC

Wei, YY; Liang, JY; Zhang, RY; Guo, YC; Shen, SP; Su, L; Lin, XH; Moran, S; Helland, A; Bjaanaes, MM; Karlsson, A; Planck, M; Esteller, M; Fleischer, T; Staaf, J; Zhao, Y; Chen, F; Christiani, DC

Chen, F (reprint author), Nanjing Med Univ, Sch Publ Hlth, Dept Biostat, Nanjing 211166, Jiangsu, Peoples R China.; Chen, F; Christiani, DC (reprint author), Nanjing Med Univ, China Int Cooperat Ctr CICC Environm & Human Hlth, Nanjing 211166, Jiangsu, Peo

CLINICAL EPIGENETICS, 2018; 10 ():

Abstract

Background: KDM lysine demethylase family members are related to lung cancer clinical outcomes and are potential biomarkers for chemotherapeutics. How......

Full Text Link